HLA-DRB1 rs2395029: Understanding Multiple Sclerosis Risk
The rs2395029 variant is a genetic marker located within the HLA-DRB1 gene region, which is strongly associated with susceptibility to multiple sclerosis (MS). It is most notably linked to the HLA-DRB1*15:01 allele, a well-documented genetic risk factor for the development of this autoimmune condition.
What each genotype means
Multiple sclerosis risk factor
This genotype is associated with the HLA-DRB1*15:01 allele, which is a well-established genetic risk factor for multiple sclerosis. Research indicates that carrying this variant increases susceptibility to the condition, though it is not a diagnostic indicator and many individuals with this genotype will never develop the disease.
This genotype is highly prevalent in populations of European ancestry and varies significantly across other global populations.
Multiple sclerosis risk factor
This genotype is associated with the HLA-DRB1*15:01 allele, which is a well-established genetic risk factor for multiple sclerosis. Research indicates that carrying this variant increases susceptibility to the condition, though it is not a diagnostic indicator and many individuals with this genotype will never develop the disease.
This genotype is highly prevalent in populations of European ancestry and varies significantly across other global populations.
Baseline risk profile
This genotype does not carry the specific HLA-DRB1*15:01 risk association linked to multiple sclerosis. While this variant is a major genetic contributor to MS risk, it is only one of many factors, and individuals with this genotype may still have other genetic or environmental influences on their health.
This genotype is common in many populations, though its frequency relative to the risk-associated allele varies significantly by ancestry.
What is rs2395029 and the HLA-DRB1 Gene?
The rs2395029 variant is a single nucleotide polymorphism (SNP) situated within the human leukocyte antigen (HLA) complex on chromosome 6. This region is highly complex and contains genes essential for the immune system's ability to distinguish between the body's own proteins and foreign invaders. The HLA-DRB1 gene specifically encodes a protein that plays a critical role in the major histocompatibility complex (MHC) class II, which presents peptide antigens to T-cells to initiate an immune response. Because of its location, rs2395029 serves as a proxy or marker for specific HLA-DRB1 alleles, most notably the HLA-DRB1*15:01 haplotype. Understanding this variant requires looking at the broader genetic architecture of the HLA region, where multiple genes are inherited together in blocks known as haplotypes. These haplotypes are highly polymorphic, meaning there is immense variation between individuals, which influences how our immune systems recognize and react to various environmental triggers.
Research Associations with Multiple Sclerosis
The association between the HLA-DRB1*15:01 allele and multiple sclerosis is one of the most robust findings in the field of autoimmune genetics. Research consistently identifies this allele as a primary genetic susceptibility factor for MS in European populations. While the exact molecular mechanism remains a subject of ongoing investigation, it is hypothesized that the protein produced by this allele may present self-antigens to the immune system in a way that triggers the inflammatory response characteristic of MS. Studies have shown that individuals carrying this risk factor may experience earlier disease onset and higher lesion volumes in the brain and spinal cord. However, it is important to note that carrying this variant does not guarantee the development of MS. Many individuals without the disease carry the allele, and many with the disease do not, indicating that MS is a complex, multifactorial condition influenced by a combination of genetic, environmental, and lifestyle factors.
Population Frequency and Ancestry
The frequency of the HLA-DRB1*15:01 allele, and by extension the associated rs2395029 marker, varies significantly across different global populations. It is most prevalent in individuals of European ancestry, where it is considered a major genetic risk factor. In contrast, the frequency of this specific allele is much lower in other populations, such as those of East Asian or African descent, where different HLA alleles may play a more prominent role in MS susceptibility. For instance, in Japanese populations, other alleles like HLA-DRB1*04:05 have been identified as significant risk factors. Because of this high degree of population-specific variation, the predictive value of this genetic marker is highly dependent on an individual's ancestral background. Researchers emphasize that genetic risk scores for complex diseases like MS must be interpreted within the context of an individual's specific genetic heritage to avoid misinterpretation of risk.
Interpreting Your Genetic Information
If you have received information about your status for rs2395029, it is essential to understand that this is a statistical association, not a diagnostic tool. Genetic testing for this variant is not used to diagnose multiple sclerosis, as the condition is diagnosed through clinical evaluation, neurological exams, and imaging studies like MRI. Because the evidence for this variant is limited to its role as a risk factor, it cannot predict whether an individual will develop the disease. If you are concerned about your health or family history of autoimmune conditions, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can help you interpret your results in the context of your overall health and family history. Never use genetic information to make medical decisions or alter treatments without direct guidance from your clinician, as they are the only ones qualified to provide medical advice based on your unique clinical profile.
How common is this variant?
The frequency of the HLA-DRB1*15:01 allele is highest in European populations and varies significantly across other global ancestries.
Frequently asked questions
Does having the rs2395029 variant mean I will get MS?
No. This variant is a risk factor, not a cause. Many people with this variant never develop multiple sclerosis, and many people with MS do not carry this specific variant.
Can I use this test to diagnose multiple sclerosis?
No. Multiple sclerosis is a clinical diagnosis made by a neurologist based on symptoms, physical exams, and imaging tests like MRIs. Genetic markers are not used for diagnosis.
Why is this variant more common in some populations?
Genetic variation in the HLA region is influenced by evolutionary history and natural selection. Different populations have developed different immune profiles over thousands of years, leading to variations in allele frequencies.
Should I be worried if I have the risk genotype?
Genetic risk factors are only one piece of a very large puzzle. If you are concerned about your health, the best approach is to discuss your family history and any symptoms with your doctor.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2395029?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HLA-DRB1
This variant is a well-established marker in the HLA region significantly associated with susceptibility to rheumatoid arthritis and other immune-mediated conditions.
This variant is a lead signal in the HLA region associated with susceptibility to nodular sclerosis Hodgkin lymphoma.
Variant in the HLA-DRB1 region associated with inflammatory bowel disease (IBD) severity and clinical outcomes.
An intergenic/intronic HLA class II variant significantly associated with multiple allergic sensitization phenotypes including pollen and animal dander.
This variant is a significant genetic marker for susceptibility to Parkinson's disease.
This SNP is linked to immune response regulation and autoimmune disease risk.